| Particulars |
|
|
|
| Company Name
| Jagsonpal Pharmaceuticals Ltd
| Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
13.36 |
B.V. (₹) |
37.90 |
| Sales(₹ Cr.) |
268.72 |
NP (₹ Cr.) |
39.70 |
| NP Var (%) |
77.00 |
Div% |
125.00 |
| CPS(₹) |
7.20 |
EPS (₹) |
5.90 |
| Traded Value(₹ Lakhs) |
30.44 |
52 Week High |
328.00 |
| 52 Week Low |
194.00 |
Price BSE |
216.00 |
| Price NSE |
216.00 |
Market Capital (₹ Cr.) |
1,439.14 |
| P/C Ratio |
30.20 |
P/E Ratio |
36.30 |
| Price Vs.BV |
5.70 |
|
| Latest Quarter |
| Year End |
202509 |
Sales (₹ Cr.) |
74.47 |
| NP(₹ Cr.) |
12.57 |
NP Var % |
10.00 |
| Trailing Twelve Months |
| Year End |
202509 |
Sales |
226.85 |
| OPM |
2.79 |
NP |
26.76 |
| NP Var (%) |
63.48 |
EPS |
6.55 |
| PE |
32.90 |
|
|